
Choice of antithrombotic therapy folowing trans-catheter aortic valve replacement (TAVR) has been evaluated in several recent clinical trials. Initially, consensus guidelines recommended dual antiplatelet therapy with aspirin plus clopidogrel based on expert opinion. Responding to concerns regarding subdinical leaflet thrombosis raised in observational studies,
Like
Save
Share